Peter Kaiser

Insider Reports History

Location
Bedford, MA
Signature
/s/ Todd Anderman, Attorney-in-Fact for Peter Kaiser
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Kaiser:

Company Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Development Officer Common Stock 269,108 $2,228,214 $8.28 23 Feb 2026 Direct
OCULAR THERAPEUTIX, INC Chief Development Officer Stock Option (Right to Buy) 240,932 02 Jan 2026 Direct

Insider Reports Filed by Peter Kaiser

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCUL OCULAR THERAPEUTIX, INC 23 Feb 2026 1 -$23,267 4 Chief Development Officer 25 Feb 2026, 18:19
OCUL OCULAR THERAPEUTIX, INC 02 Jan 2026 2 $0 4 Chief Development Officer 06 Jan 2026, 16:05
OCUL OCULAR THERAPEUTIX, INC 24 Nov 2025 1 -$36,144 4 Chief Development Officer 26 Nov 2025, 16:01
OCUL OCULAR THERAPEUTIX, INC 02 Oct 2025 1 -$106,473 4 Chief Development Officer 06 Oct 2025, 17:13
OCUL OCULAR THERAPEUTIX, INC 25 Aug 2025 1 -$36,252 4 Chief Development Officer 27 Aug 2025, 18:44
OCUL OCULAR THERAPEUTIX, INC 23 May 2025 1 -$21,324 4 Chief Development Officer 27 May 2025, 17:40
OCUL OCULAR THERAPEUTIX, INC 24 Feb 2025 1 -$20,672 4 Chief Development Officer 26 Feb 2025, 18:24
OCUL OCULAR THERAPEUTIX, INC 25 Nov 2024 1 -$26,102 4 Chief Development Officer 27 Nov 2024, 07:51
OCUL OCULAR THERAPEUTIX, INC 02 Oct 2024 2 $0 4 Chief Development Officer 04 Oct 2024, 17:21
OCUL OCULAR THERAPEUTIX, INC 02 Oct 2024 0 $0 3 Chief Development Officer 04 Oct 2024, 17:18